RE: RNS Out - Prospectus Approved!28 Jul 2025 14:14
The non-executive Directors contributed an additional £350,000 to the raise, reflecting confidence in the new direction.
The funding will support:
· Recruitment of key technical and operational personnel
· Rapid development of prototypes across all four technology pillars
· Initial deployments and pilot programmes with government and defence partners
· Expansion of research partnerships with UK and European innovation ecosystems
The Company now operates with a streamlined cost base and no significant legacy liabilities, allowing for focused capital deployment and growth.